1. Zhou, Yajing, Chai, Hua, Guo, Lei, Liu, Yanting, Ding, Qian. . Knockdown of CENPW Inhibits Hepatocellular Carcinoma Progression by Inactivating E2F Signaling. In Technology in cancer research & treatment, 20, 15330338211007253. doi:10.1177/15330338211007253. https://pubmed.ncbi.nlm.nih.gov/33973496/
2. Wang, Yangwei, Chen, Jiaping, Meng, Wangyang, Xiao, Han, Liao, Yongde. 2023. A five-gene expression signature of centromeric proteins with prognostic value in lung adenocarcinoma. In Translational cancer research, 12, 273-286. doi:10.21037/tcr-22-2166. https://pubmed.ncbi.nlm.nih.gov/36915596/
3. Wang, Luyang, Wang, Hairui, Yang, Chen, Li, Yanchun, Wang, Ying. 2022. Investigating CENPW as a Novel Biomarker Correlated With the Development and Poor Prognosis of Breast Carcinoma. In Frontiers in genetics, 13, 900111. doi:10.3389/fgene.2022.900111. https://pubmed.ncbi.nlm.nih.gov/35783290/
4. Zhang, Peng, Yang, Qian, Chen, Xulong, Jiang, Kehua, Sun, Fa. 2024. CENPW knockdown inhibits progression of bladder cancer through inducing cell cycle arrest and apoptosis. In Journal of Cancer, 15, 858-870. doi:10.7150/jca.90449. https://pubmed.ncbi.nlm.nih.gov/38213721/
5. Zhou, Ziliang, Zhou, Zhechong, Huang, Zhaoxia, He, Suhua, Chen, Shoudeng. . Histone-fold centromere protein W (CENP-W) is associated with the biological behavior of hepatocellular carcinoma cells. In Bioengineered, 11, 729-742. doi:10.1080/21655979.2020.1787776. https://pubmed.ncbi.nlm.nih.gov/32635817/
6. Huang, Tingxuan, Peng, Yulu, Liu, Ruiqi, He, Liru, Dong, Pei. 2024. Prognostic significance of immune evasion-related genes in clear cell renal cell carcinoma immunotherapy. In International immunopharmacology, 142, 113106. doi:10.1016/j.intimp.2024.113106. https://pubmed.ncbi.nlm.nih.gov/39288623/
7. Jiang, Lin, Liao, Junzuo, Han, Yunwei. 2023. Study on the role and pharmacology of cuproptosis in gastric cancer. In Frontiers in oncology, 13, 1145446. doi:10.3389/fonc.2023.1145446. https://pubmed.ncbi.nlm.nih.gov/37007099/
智鼠故事 
